Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Price:
3.8 USD
8.57%
Market Closed
Updated:
May 14, 2024
Adaptive Biotechnologies Corp
Change in Working Capital
|
Adaptive Biotechnologies Corp
Change in Working Capital Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
Change in Working Capital
-$32m
|
CAGR 3-Years
22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Change in Working Capital
-$537m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Danaher Corp
NYSE:DHR
|
Change in Working Capital
$871m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Change in Working Capital
$100m
|
CAGR 3-Years
17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Agilent Technologies Inc
NYSE:A
|
Change in Working Capital
$95m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Change in Working Capital
-$280m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
See Also
What is Adaptive Biotechnologies Corp's Change in Working Capital?
Change in Working Capital
-32m
USD
-32m
USD
Based on the financial report for Mar 31, 2024, Adaptive Biotechnologies Corp's Change in Working Capital amounts to -32m USD.
What is Adaptive Biotechnologies Corp's Change in Working Capital growth rate?
Change in Working Capital CAGR 3Y
22%
22%
Over the last year, the Change in Working Capital growth was 57%. The average annual Change in Working Capital growth rates for Adaptive Biotechnologies Corp have been 22% over the past three years .
You don't have any saved screeners yet
